Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands

Critical Care

Volumn 14, Issue 6, 2010, Pages

  Al, Maiwenn J ^a   Hakkaart, Leona ^a   Tan, Siok Swan ^a   Bakker, Jan ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; LORAZEPAM; MIDAZOLAM; MORPHINE; PROPOFOL; REMIFENTANIL; SUFENTANIL CITRATE; PIPERIDINE DERIVATIVE;

ANALGESIA; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROSSOVER PROCEDURE; DRUG COST; EXTUBATION; HIDDEN MARKOV MODEL; HOSPITAL COST; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NETHERLANDS; OPEN STUDY; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; SEDATION; VENTILATED PATIENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONSCIOUS SEDATION; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; FOLLOW UP;

ANALGESIA; CONSCIOUS SEDATION; COST-BENEFIT ANALYSIS; CROSS-OVER STUDIES; FOLLOW-UP STUDIES; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; NETHERLANDS; PIPERIDINES; RESPIRATION, ARTIFICIAL;

EID: 77958553840     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9313     Document Type: Article

References (30)

1. Gravel NR, Searle NR, Sahab PG, Carrier M. Sedation in critically ill patients: practical recommendations. CNS Drugs 1999, 11:9-22.
2. Egan TD, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993, 79:881-892. 10.1097/00000542-199311000-00004, 7902032.
3. Andrews P, Azoulay E, Antonelli M, Brochard L, Brun-Buisson C, Dobb G, Fagon JY, Gerlach H, Groeneveld J, Mancebo J, Metnitz P, Nava S, Pugin J, Pinsky M, Radermacher P, Richard C, Tasker R. Year in review in intensive care medicine, 2005. II. Infection and sepsis, ventilator-associated pneumonia, ethics, haematology and haemostasis, ICU organisation and scoring, brain injury. Intensive Care Med 2006, 32:380-390. 10.1007/s00134-005-0060-y, 16485094.
4. Andrews P, Azoulay E, Antonelli M, Brochard L, Brun-Buisson C, De Backer D, Dobb G, Fagon JY, Gerlach H, Groeneveld J, Macrae D, Mancebo J, Metnitz P, Nava S, Pugin J, Pinsky M, Radermacher P, Richard C. Year in review in Intensive Care Medicine, 2006. II. Infections and sepsis, haemodynamics, elderly, invasive and noninvasive mechanical ventilation, weaning, ARDS. Intensive Care Med 2007, 33:214-229. 10.1007/s00134-006-0512-z, 17221187.
5. Mehta S, Hill NS. Noninvasive ventilation. Am J Respir Crit Care Med 2001, 163:540-577.
6. Battershill AJ, Keating GM. Remifentanil: a review of its analgesic and sedative use in the intensive care unit. Drugs 2006, 66:365-385. 10.2165/00003495-200666030-00013, 16526829.
7. James MK, Feldman PL, Schuster SV, Bilotta JM, Brackeen MF, Leighton HJ. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991, 259:712-718.
8. Kapila A, Glass PS, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 1995, 83:968-975. 10.1097/00000542-199511000-00009, 7486182.
9. Westmoreland CL, Hoke JF, Sebel PS, Hug CC, Muir KT. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 1993, 79:893-903. 10.1097/00000542-199311000-00005, 7902033.
10. Gusmao Vicente F, Polito Lomar F, Melot C, Vincent JL. Can the experienced ICU physician predict ICU length of stay and outcome better than less experienced colleagues?. Intensive Care Med 2004, 30:655-659. 10.1007/s00134-003-2139-7, 14735235.
11. Rozendaal FW, Spronk PE, Snellen FF, Schoen A, van Zanten AR, Foudraine NA, Mulder PG, Bakker J. Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med 2009, 35:291-298. 10.1007/s00134-008-1328-9, 18949456.
12. GlaxoSmithKline: Fachinformation Ultiva. , http://ch.oddb.org/de/gcc/resolve/pointer/%3A!fachinfo,24352583.
13. Tan SS, Hakkaart-van Roijen L, Al MJ, Bouwmans CA, Hoogendoorn ME, Spronk PE, Bakker J. A microcosting study of intensive care unit stay in the Netherlands. J Intensive Care Med 2008, 23:250-257. 10.1177/0885066608318661, 18508839.
14. Efron B, Tibshirani RJ. An Introduction to the Bootstrap 1993, New York: Chapman and Hall.
15. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999, 18:341-364. 10.1016/S0167-6296(98)00039-3, 10537899.
16. NICE: Guide to the Methods of Technology Appraisal. , http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf
17. Grosse SD. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res 2008, 8:165-178. 10.1586/14737167.8.2.165, 20528406.
18. Muellejans B, Matthey T, Scholpp J, Schill M. Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial [abstract]. Crit Care 2006, 10:R91. 10.1186/cc4939, 1550941, 16780597.
19. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903.
20. Langer M, Mosconi P, Cigada M, Mandelli M. Long-term respiratory support and risk of pneumonia in critically ill patients. Intensive Care Unit Group of Infection Control. Am Rev Respir Dis 1989, 140:302-305.
21. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke RZ, Brun-Buisson C. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998, 129:433-440.
22. Hugonnet S, Eggimann P, Borst F, Maricot P, Chevrolet JC, Pittet D. Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol 2004, 25:1090-1096. 10.1086/502349, 15636298.
23. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, Kollef MH. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002, 122:2115-2121. 10.1378/chest.122.6.2115, 12475855.
24. Nseir S, Hoel J, Grailles G, Soury-Lavergne A, Di Pompeo C, Mathieu D, Durocher A. Remifentanil discontinuation and subsequent intensive care unit-acquired infection: a cohort study. Crit Care 2009, 13:R60. 10.1186/cc7788, 2689508, 19383164.
25. Feng P, Wilson QM, Meissler JJ, Adler MW, Eisenstein TK. Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12. Infect Immun 2005, 73:7953-7959. 10.1128/IAI.73.12.7953-7959.2005, 1307081, 16299287.
26. Feng P, Truant AL, Meissler JJ, Gaughan JP, Adler MW, Eisenstein TK. Morphine withdrawal lowers host defense to enteric bacteria: spontaneous sepsis and increased sensitivity to oral Salmonella enterica serovar Typhimurium infection. Infect Immun 2006, 74:5221-5226. 10.1128/IAI.00208-06, 1594820, 16926415.
27. Cammarano WB, Pittet JF, Weitz S, Schlobohm RM, Marks JD. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med 1998, 26:676-684. 10.1097/00003246-199804000-00015, 9559604.
28. Delvaux B, Ryckwaert Y, Van Boven M, De Kock M, Capdevila X. Remifentanil in the intensive care unit: tolerance and acute withdrawal syndrome after prolonged sedation. Anesthesiology 2005, 102:1281-1282. 10.1097/00000542-200506000-00030, 15915043.
29. Muellejans B, Lopez A, Cross MH, Bonome C, Morrison L, Kirkham AJ. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial (ISRCTN43755713). Crit Care 2004, 8:R1-R11. 10.1186/cc2398, 420059, 14975049.
30. Breen D, Karabinis A, Malbrain M, Morais R, Albrecht S, Jarnvig IL, Parkinson P, Kirkham AJ. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial (ISRCTN47583497). Crit Care 2005, 9:R200-210. 10.1186/cc3495, 1175879, 15987391.